Track the 서울바이오시스 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Technology sector, 서울바이오시스 has published 22 insider filings. Market capitalisation: €426bn. The latest transaction was reported on 10 March 2026 (Other). Among the most active insiders: 서울반도체. All data is openly available.
22
Insider Decl.
0
Thresholds
·
12 ops.
Buy Volume
·
0 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 15,417 of 26,211 companies
46.6
score / 100
Value
59
Quality
34
FCF yld8.8%
Earn yld-5.4%
EV/EBITDA6.7x
ROE9.2%
Gross mgn14%
Net mgn-2.0%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.